Physician profile
Deepak N Gaba
NPI 1366404782
$11,540.39
in general payments reported to CMS, 2019-2025
24 companies · $5,786 in 2025
The $5,786 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,970 · 2020: $200 · 2021: $347 · 2022: $575 · 2023: $238 · 2024: $425 · 2025: $5,786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,231 · Food and Beverage: $3,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,231.38 |
| Food and Beverage | $3,217.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,443.98 | 2021-2025 | Micra, Affera Mapping System, Linq II |
| Boston Scientific Corporation | $2,076.10 | 2019-2023 | Watchman Access System, Watchman Flx |
| Medical Device Business Services, INC. | $1,980.55 | 2019 | |
| Biosense Webster, INC. | $613.63 | 2019-2025 | Carto 3 |
| Janssen Pharmaceuticals, INC | $288.41 | 2019-2021 | |
| Cardiva Medical, INC. | $277.04 | 2021-2025 | Ensoetm, Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Novartis Pharmaceuticals Corporation | $187.53 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $123.60 | 2019-2025 | Lifevest |
| Abbott Laboratories | $122.23 | 2020-2025 | Ensite, Cardiomems, Assurity |
| Biotronik INC. | $56.88 | 2019 | |
| Pfizer INC. | $40.52 | 2019-2025 | |
| Ethicon US, LLC | $38.81 | 2025 | Stratafix, Surgicel Nu-Knit, Vistaseal |
| Actelion Pharmaceuticals US, INC. | $38.69 | 2019-2024 | Uptravi, Opsumit |
| Medtronic Vascular, INC. | $37.14 | 2019 | |
| Amgen INC. | $31.85 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $27.62 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Alnylam Pharmaceuticals INC. | $26.42 | 2025 | Onpattro |
| Sanofi-Aventis U.S. LLC | $26.34 | 2019 | |
| Merck Sharp & Dohme LLC | $23.94 | 2024 | Verquvo |
| Cardiovascular Systems INC. | $23.67 | 2021 | |
| Chiesi USA, INC. | $15.02 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.40 | 2019 | |
| Getinge USA Sales, LLC | $13.22 | 2022 | |
| Terumo Medical Corporation | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Gaba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.